Represents the amount related to derivative liabilities settled through issuance of shares.

No definition available.

Name:	huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares
Namespace Prefix:	huge_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the number of additional shares issued to settle derivative liability.

+ References

No definition available.

+ Details

Name:	huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability
Namespace Prefix:	huge_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents number of shares sold.

+ References

No definition available.

+ Details

Name:	huge_NumberOfSharesSold
Namespace Prefix:	huge_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of instruments granted in share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 2
-IssueDate 2019-01-01
-Paragraph IG23
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_IG23&doctype=Implementation%20Guidance
-URIDate 2019-03-27

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 2
-IssueDate 2019-01-01
-Paragraph 45
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45_a&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2019-01-01
-Paragraph 17
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2019-en-r&anchor=para_17&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_ProceedsFromIssueOfOrdinaryShares
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent events (Narrative) (Details) - Class B shares - Subsequent events	Feb. 05, 2020 CAD ($) shares	Feb. 04, 2020 CAD ($) shares	Jan. 02, 2020 Share
Disclosure of non-adjusting events after reporting period [line items]
Number of instruments granted in share-based payment arrangement \| Share			27,580
Solarvest BioEnergy Inc.
Disclosure of non-adjusting events after reporting period [line items]
Number of additional shares issued to settle derivative liability \| shares		225,371
Derivative liabilities settled through issuance of shares \| $		$ 2,646,269
Cannara Biotech Inc.
Disclosure of non-adjusting events after reporting period [line items]
Number of shares sold for investment in Cannara \| shares	85,003,750
Gross proceeds of common stock \| $	$ 7,743,492